Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs

Damani Arnold Piggott, Kristine M. Erlandson, Kevin E. Yarasheski

Research output: Contribution to journalArticle


Frailty is a critical aging-related syndrome marked by diminished physiologic reserve and heightened vulnerability to stressors, predisposing to major adverse clinical outcomes, including hospitalization, institutionalization, disability, and death in the general population of older adults. As the proportion of older adults living with HIV increases in the era of antiretroviral therapy, frailty is increasingly recognized to be of significant clinical and public health relevance to the HIV-infected population. This article reviews current knowledge on the epidemiology and biology of frailty and its potential role as a target for reducing disparities in outcomes in HIV; conceptual frameworks and current approaches to frailty measurement; existing data on frailty interventions; and important areas for future research focus necessary to develop and advance effective strategies to prevent or ameliorate frailty and its marked adverse consequences among people living with HIV.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalCurrent HIV/AIDS Reports
StateAccepted/In press - Aug 22 2016


  • Clinical outcomes
  • Deficit accumulation index
  • Disparities
  • Immunosenescence
  • Physical activity
  • Physical frailty phenotype

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs'. Together they form a unique fingerprint.

  • Cite this